Type I Gastric Carcinoids: Clinical Trials

2 trials for Type I Gastric Carcinoids, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1

Follow Type I Gastric Carcinoids: new trials by email Literature Review of Type I Gastric Carcinoids trials Research Report on Type I Gastric Carcinoids

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
YF476 and Type I Gastric Carcinoids (Norway)
YF476 - Chronic Atrophic Gastritis, Hypergastrinemia
Phase 2TerminatedTrio Medicines Ltd.82011-06-012015-05-15
YF476 and Type I Gastric Carcinoids
YF476 - Chronic Atrophic Gastritis, Hypergastrinaemia
Phase 2CompletedTrio Medicines Ltd.82011-01-042019-08-19

Narrower conditions

Gastritis, Atrophic (2)

Broader conditions

Digestive System Diseases (2)  ·  Gastritis (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Stomach Diseases (2)

Interventions

YF 476 (2)

Sponsors

Trio Medicines Ltd. (2)

Countries

Norway (1)  ·  United Kingdom (1)

Top investigators

Malcolm Boyce, BSc FRCP FFPM (2)  ·  Helge Waldum, MD PhD (1)  ·  Mark Pritchard, PhD FRCP (1)

Results publications

PMID 24098507